Efek Depresi terhadap Efektivitas Pengobatan Penyakit Crohn
DOI:
https://doi.org/10.59680/ventilator.v2i3.1372Keywords:
Depression, treatment efficacy, Crohn's diseaseAbstract
Crohn's disease is a chronic inflammatory condition of the gastrointestinal tract that is often accompanied by psychological disorders such as depression. This study aims to analyze the impact of depression on the effectiveness of Crohn's disease treatment through a systematic review and meta-analysis. A literature search was conducted across electronic databases, including PubMed, Scopus, and Web of Science, for studies published in the last five years. Of the 1,247 articles identified, 28 studies met the inclusion criteria. The meta-analysis results indicate that Crohn's disease patients with depression have a lower remission rate (OR = 0.65, 95% CI: 0.54-0.78) and a higher relapse rate (HR = 1.58, 95% CI: 1.32-1.89) compared to patients without depression. Additionally, subgroup analysis reveals that the negative effects of depression are more pronounced in patients receiving biological therapy. These findings underscore the importance of a holistic approach in the management of Crohn's disease, considering the psychological aspects of patients to optimize treatment outcomes.
References
Ananthakrishnan, A. N., Khalili, H., Pan, A., Higuchi, L. M., de Silva, P., Richter, J. M., ... & Chan, A. T. (2013). Association between depressive symptoms and incidence of Crohn's disease and ulcerative colitis: Results from the Nurses' Health Study. Clinical Gastroenterology and Hepatology, 11(1), 57-62. https://doi.org/10.1016/j.cgh.2012.08.036
Baumgart, D. C., & Sandborn, W. J. (2012). Crohn's disease. The Lancet, 380(9853), 1590-1605. https://doi.org/10.1016/S0140-6736(12)60026-9
Bonaz, B. L., & Bernstein, C. N. (2013). Brain-gut interactions in inflammatory bowel disease. Gastroenterology, 144(1), 36-49. https://doi.org/10.1053/j.gastro.2012.10.020
Cámara, R. J., Schoepfer, A. M., Pittet, V., Begré, S., von Känel, R., & Swiss Inflammatory Bowel Disease Cohort Study Group. (2011). Mood and nonmood components of perceived stress and exacerbation of Crohn's disease. Inflammatory Bowel Diseases, 17(11), 2358-2365. https://doi.org/10.1002/ibd.21592
Drevets, W. C., Price, J. L., & Furey, M. L. (2008). Brain structural and functional abnormalities in mood disorders: Implications for neurocircuitry models of depression. Brain Structure and Function, 213(1-2), 93-118. https://doi.org/10.1007/s00429-008-0189-1
Engel, G. L. (1977). The need for a new medical model: A challenge for biomedicine. Science, 196(4286), 129-136. https://doi.org/10.1126/science.881119
Feuerstein, J. D., Isaacs, K. L., Schneider, Y., Siddique, S. M., Falck-Ytter, Y., Singh, S., & AGA Institute Clinical Guidelines Committee. (2020). AGA Clinical Practice Guidelines on the management of moderate to severe ulcerative colitis. Gastroenterology, 158(5), 1450-1461. https://doi.org/10.1053/j.gastro.2019.12.007
Frolkis, A. D., Vallerand, I. A., Shaheen, A. A., Lowerison, M. W., Swain, M. G., Barnabe, C., ... & Kaplan, G. G. (2019). Depression increases the risk of inflammatory bowel disease, which may be mitigated by the use of antidepressants in the treatment of depression. Gut, 68(9), 1606-1612. https://doi.org/10.1136/gutjnl-2018-316489
GBD 2017 Inflammatory Bowel Disease Collaborators. (2020). The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. The Lancet Gastroenterology & Hepatology, 5(1), 17-30. https://doi.org/10.1016/S2468-1253(19)30333-4
Goodhand, J. R., Wahed, M., Mawdsley, J. E., Farmer, A. D., Aziz, Q., & Rampton, D. S. (2012). Mood disorders in inflammatory bowel disease: Relation to diagnosis, disease activity, perceived stress, and other factors. Inflammatory Bowel Diseases, 18(12), 2301-2309. https://doi.org/10.1002/ibd.22919
Graff, L. A., Walker, J. R., & Bernstein, C. N. (2009). Depression and anxiety in inflammatory bowel disease: A review of comorbidity and management. Inflammatory Bowel Diseases, 15(7), 1105-1118. https://doi.org/10.1002/ibd.20925
Iwata, M., Ota, K. T., & Duman, R. S. (2013). The inflammasome: Pathways linking psychological stress, depression, and systemic illnesses. Brain, Behavior, and Immunity, 31, 105-114. https://doi.org/10.1016/j.bbi.2012.08.002
Keefer, L., & Kane, S. V. (2017). Considering the bidirectional pathways between depression and IBD: Recommendations for comprehensive IBD care. Gastroenterology & Hepatology, 13(3), 164-169.
Knowles, S. R., Graff, L. A., Wilding, H., Hewitt, C., Keefer, L., & Mikocka-Walus, A. (2018). Quality of life in inflammatory bowel disease: A systematic review and meta-analyses—Part I. Inflammatory Bowel Diseases, 24(4), 742-751. https://doi.org/10.1093/ibd/izy017
Kochar, B., Barnes, E. L., Long, M. D., Cushing, K. C., Galanko, J., Martin, C. F., & Kappelman, M. D. (2018). Depression is associated with more aggressive inflammatory bowel disease. American Journal of Gastroenterology, 113(1), 80-85. https://doi.org/10.1038/ajg.2017.406
Mawdsley, J. E., & Rampton, D. S. (2005). Psychological stress in IBD: New insights into pathogenic and therapeutic implications. Gut, 54(10), 1481-1491. https://doi.org/10.1136/gut.2004.054050
Mikocka-Walus, A., Knowles, S. R., Keefer, L., & Graff, L. (2016). Controversies revisited: A systematic review of the comorbidity of depression and anxiety with inflammatory bowel diseases. Inflammatory Bowel Diseases, 22(3), 752-762. https://doi.org/10.1097/MIB.0000000000000738
Mittermaier, C., Dejaco, C., Waldhoer, T., Oefferlbauer-Ernst, A., Miehsler, W., Beier, M., ... & Moser, G. (2004). Impact of depressive mood on relapse in patients with inflammatory bowel disease: A prospective 18-month follow-up study. Psychosomatic Medicine, 66(1), 79-84. https://doi.org/10.1097/01.PSY.0000106903.22077.4F
Panara, A. J., Yarur, A. J., Rieders, B., Proksell, S., Deshpande, A. R., Abreu, M. T., & Sussman, D. A. (2014). The incidence and risk factors for developing depression after being diagnosed with inflammatory bowel disease: A cohort study. Alimentary Pharmacology & Therapeutics, 39(8), 802-810. https://doi.org/10.1111/apt.12674
Persoons, P., Vermeire, S., Demyttenaere, K., Fischler, B., Vandenberghe, J., Van Oudenhove, L., ... & Rutgeerts, P. (2005). The impact of major depressive disorder on the short- and long-term outcome of Crohn's disease treatment with infliximab. Alimentary Pharmacology & Therapeutics, 22(2), 101-110. https://doi.org/10.1111/j.1365-2036.2005.02531.x
Porcelli, P., Leoci, C., & Guerra, V. (1996). A prospective study of the relationship between disease activity and psychologic distress in patients with inflammatory bowel disease. Scandinavian Journal of Gastroenterology, 31(8), 792-796. https://doi.org/10.3109/00365529609005360
Sexton, K. A., Walker, J. R., Graff, L. A., Bernstein, M. T., Beatie, B., Miller, N., & Bernstein, C. N. (2017). Evidence of bidirectional associations between perceived stress and symptom activity: A prospective longitudinal investigation in inflammatory bowel disease. Inflammatory Bowel Diseases, 23(3), 473-483. https://doi.org/10.1097/MIB.0000000000000998
Tabibian, A., Tabibian, J. H., Beckman, L. J., Raffals, L. L., Papadakis, K. A., & Kane, S. V. (2015). Predictors of health-related quality of life and adherence in Crohn's disease and ulcerative colitis: Implications for clinical management. Digestive Diseases and Sciences, 60(5), 1366-1374. https://doi.org/10.1007/s10620-014-3424-4
Torres, J., Mehandru, S., Colombel, J. F., & Peyrin-Biroulet, L. (2017). Crohn's disease. The Lancet, 389(10080), 1741-1755. https://doi.org/10.1016/S0140-6736(16)31711-1
van Langenberg, D. R., Lange, K., Hetzel, D. J., Holtmann, G. J., & Andrews, J. M. (2012). Adverse clinical phenotype in inflammatory bowel disease: A cross sectional study identifying factors potentially amenable to change. Journal of Gastroenterology and Hepatology, 27(7), 1204-1210. https://doi.org/10.1111/j.1440-1746.2011.06995.x
Zhang, C., Byrne, G., Lee, T., Singer, J., Giustini, D., & Bressler, B. (2018). Incidence of suicide in inflammatory bowel disease: A systematic review and meta-analysis. Journal of the Canadian Association of Gastroenterology, 1(3), 107-114. https://doi.org/10.1093/jcag/gwy016
